SynthesisHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2021

Glucagon-like Peptide-1 Receptor Agonists and Cardioprotective Benefit in Patients with Type 2 Diabetes Without Baseline Metformin: A Systematic Review and Update Meta-analysis.

Augusto Lavalle-Cobo et al.PubMed ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation, not cause

−14%−21% to −6%

Bigger than 3 in 10 for cardiovascular events

As reported

HR 0.86, 95% CI 0.79–0.94

the abstract, start to end

… reduction in MACE incidence (HR: 0.86, 95% confidence interval: …

← favours treatmentfavours comparator →

could be chance

Cardiovascular events

HR 0.860.79–0.94

MetforminCardiovascular events

1 / 3

2021

2022

2023

2024

2025

this papercites it